Nessan Bermingham

Nessan Bermingham is an accomplished professional with extensive background in biotechnology and venture capital. Currently serving as an Operating Partner at Khosla Ventures since December 2021, Bermingham also holds board member positions at multiple organizations, including Ochre Bio, CellFE, Deep Genomics, and Liberate Bio, the latter of which Bermingham founded. As Interim CEO and a board member at EveryONE Medicines, Inc., Bermingham has made significant contributions to the field. Previous roles include Founder and Executive Chair at Korro Bio, Inc., Chairperson at F-star Therapeutics, and CEO of Triplet Therapeutics. Bermingham's academic credentials include a Doctor of Philosophy in Molecular Biology from Imperial College London and postdoctoral research at Baylor College of Medicine.